Work

Implications of the chromatin remodeling complex SWI/SNF in lung cancer

Year: 2022
Type: dissertation
Abstract: SWI/SNF (SWItch/Sucrose Non-Fermentable) complexes are ATP-dependent \nchromatin remodelers composed of varying combinations of subunits that, together, \nfine-tune relevant biological processes, such as transcriptional regulation and \ngenome integrity. Moreover, the subunits of this chromatin remodeler have been \nidentified as major targets of mutations in several tumor types underlying a relevant \nrole in tumorigenesis. However, there is a lack of comprehensive studies of the \nwhole SWI/SNF complex in lung adenocarcinoma (LUAD), and its clinical \nimplications are not yet fully understood. In this Ph.D. thesis, we combine genomic, \ntranscriptomic, and proteomic techniques to identify which SWI/SNF subunits are \npresent in lung epithelial cells, as well as to determine their mutational status and \nexpression levels in LUAD in a more integrative manner. For these purposes, we \nanalyzed data from LUAD primary tumors, normal lung and LUAD cell lines, and \nexternal LUAD data from The Cancer Genome Atlas. We found that SWI/SNF \ncomplex mutations not only present a high incidence of 41.4% in LUAD patients and \n76% in LUAD cell lines, but also the mutational status of the SWI/SNF complex was \nassociated with poorer overall survival of LUAD patients and higher tumor mutation \nburdens. Furthermore, we observed that the expression of the SWI/SNF complex in \nLUAD suffers overall repression, which cannot be exclusively explained by genetic \nalterations. Based on our findings, we propose that SWI/SNF-mutant LUAD tumors \ncould be considered as a clinical subgroup with applications in the prognosis of \nLUAD patients. In addition, we chose different LUAD cell models to perform various \nfunctional experiments to answer two of the open-ended questions related to the \nrole of the SWI/SNF complex in cancer. On the one hand, we studied the function of \nthe SWI/SNF complex in the regulation of the non-protein-coding part of the \ngenome, such as microRNAs, which are small RNAs with key regulatory functions \nand whose expression is frequently altered in cancer. Specifically, we used a \nSMARCA4-deficient model of LUAD cells to track changes in the miRNome upon \nSMARCA4 restoration. We found that the SWI/SNF complex, when SMARCA4 was \nthe catalytic subunit, induced the expression of miR-222 through its direct binding \nto the enhancer region of this microRNA. Furthermore, we demonstrated that the \noverexpression of miR-222 phenocopied the tumor suppressor effect of SMARCA4 in LUAD. Thus, these results highlight the importance of considering microRNAs as \nanother layer of regulation that can be controlled by the SWI/SNF complex with \nrelevant implications in tumor development. On the other hand, we analyzed the \nfunctional consequences of silencing ARID1A, one of the most mutated SWI/SNF \nsubunits in cancer, in different LUAD cell lines. We discovered that several LUAD cell \nlines, regardless of their genetic background, developed a dependency on ARID1A \nthat was not observed in normal lung epithelial cells. Interestingly, we found that \nARID1A loss in LUAD cells impaired proteostasis, increasing cellular stress and DNA \ndamage that led to cell death. Moreover, we observed that depleting ARID1A \nbehaved as a genotoxic treatment improving the effectiveness of other \nchemotherapy drugs used for treating lung cancer. In conclusion, our study provides \nan overview of the variety of implications of the SWI/SNF complex in LUAD, \nunderlining the unexplored potential that this chromatin remodeler has in clinical \npractice.
Author: Peinado Fernández, Paola
Language: English
Open Access status: green
OpenAlex ID: W7029156212
Cites:
Cited by:
Related to: 9